Ubiquigent

About:

Ubiquigent provides the research community with reagents, kits, and drug discovery, assay development and compound profiling services.

Website: https://ubiquigent.com/

Twitter/X: ubiquigent

Top Investors: Innovate UK, IP Group, Scottish Enterprise, UK Research and Innovation, Scottish Investment Bank

Description:

Ubiquigent Limited is a specialist developer and supplier of high quality reagents, kits and drug discovery assay development and compound profiling services to the life science research community worldwide. Ubiquigent's scientific and business interests have a clear focus; namely the ubiquitin, ubiquitin-like and integrated signalling systems. The company has established its scientific and business credentials with both academic researchers undertaking fundamental scientific discovery as well as with pharmaceutical and biotechnology company scientists exploring the potential of ubiquitin cascade-focused drug discovery.

Total Funding Amount:

500000 GBP

Headquarters Location:

Dundee, Dundee City, United Kingdom

Founded Date:

2009-01-01

Contact Email:

tech.support(AT)ubiquigent.com

Founders:

Jason Brown

Number of Employees:

1-10

Last Funding Date:

2021-01-14

IPO Status:

Private

Industries:

© 2025 bioDAO.ai